… research is required to establish its therapeutic role, and the relevant … bowel disease and
its implication for therapy. inflammatory bowel disease, smoking, nicotine, Crohn's disease …

… Anti-tumor necrosis factor alpha (ATA) therapy plays a significant role in the treatment of
moderate to severe inflammatory bowel disease (IBD). There are concerns regarding risks …

… Inflammatory bowel disease (IBD) poses formidable therapeutic challenges to the clinician
caring for patients with Crohn's disease (CD) and ulcerative colitis (UC). This is primarily …

Although the aetiology of inflammatory bowel disease (IBD) remains unknown, the
pathogenesis is gradually being unravelled, seeming to be the result of a combination of …

… PURPOSE: This study was undertaken to review the latest literature on the role of PAF
and cytokines in the genesis of inflammatory bowel disease and implications for therapy and …

… bowel disease. An important field relevant to inflammatory bowel disease therapy is the …
certain medications in order to target these therapeutic interventions more precisely. To date…

… used in treatment of inflammatory bowel disease (IBD) and has proven to be effective for
both inducing and maintaining long-term remission of Crohn's disease (CD) and ulcerative …

… bowel diseases of the intestines. Br Med J 1963;2:483-486. 7 Price WH. A high incidence of
chronic inflammatory bowel disease in … therapy in patients with inflammatory bowel disease. …

Inflammatory bowel diseases (IBD) belong to the group of immune-mediated diseases (IMIDs).
The effect of associated IMIDs in the prognosis in IBD is nowadays unknown. To describe …

… (IBD),6-12 and discuss the mucosal and luminal factors likely to account for differences in
health and disease. Lastly, we consider the therapeutic implications of altered gut pH in IBD …